Success Story: Mapping Neural Communication and Improving Neuromodulation Therapies: NIW Approved After RFE for a French Neuroscience Researcher
Client’s Testimonial:
“My experience with Chen Immigration has been great! The team is highly responsive and professional, and every question I had was answered thoroughly and with care. The petition letter they crafted was compelling and exceptionally well written.”
On April 4th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Researcher Professional 5 – Biomedical Engineering in the field of Neuroscience (Approval Notice).
General Field: Neuroscience
Position at the Time of Case Filing: Researcher Professional 5 – Biomedical Engineering
Country of Origin: France
State of Residence at the Time of Filing: Minnesota
Approval Notice Date: April 4th, 2026
Processing Time: 4 months, 3 days (Premium Processing Requested)
Case Summary:
Neurological disorders remain difficult to treat in part because neural communication varies across brain regions and can respond unpredictably to intervention. This NIW approval highlights a French researcher whose proposed endeavor focuses on recording and analyzing neural activity in healthy and diseased tissue and evaluating how neuromodulation influences brain function and behavior. At the time of filing, the client was continuing this work in the United States in a biomedical engineering research role.
Research with National Importance
The petition framed the endeavor as nationally important because neurological disorders drive long-term disability and rising healthcare costs. The filing explained that progress in neuromodulation depends on rigorous measurement and analysis of how brain regions and neuron types respond to stimulation, which can support more precise and reliable treatment approaches for high-burden conditions.
Academic Contributions and Recognition
The petition documented 6 peer-reviewed journal articles, 2 peer-reviewed conference articles, 11 abstracts, and 1 first-authored preprint, with 194 citations reflecting meaningful independent reliance on the client’s work. The filing also highlighted strong field- and year-normalized citation performance for multiple publications. Professional trust was supported through at least 6 completed peer reviews for selective journals, and the petition cited objective research support from major U.S. funding sources as an additional indicator of national relevance.
Expert Endorsements
The petition included expert letters describing why the client’s methods matter beyond a single project and support broader progress in brain health and neurotechnology.
One expert stated:
“The importance of [client]’s research to healthcare, pharmaceuticals, neurotechnology, and artificial intelligence is evident, given the breakthroughs that his research has fostered in these areas and in the field of neuroscience more generally.”
This assessment reinforced the petition’s showing that the client’s work is recognized as influential and that the client is well-positioned to continue advancing the proposed endeavor.
NIW Approval and Outlook
The I-140 NIW petition was filed on December 1st, 2025, under Premium Processing. USCIS issued an RFE on January 13th, 2026, and the case was approved on April 4th, 2026. The approval reflects a clear NIW showing that the endeavor carries substantial merit and national importance and that the client is well-positioned through an established publication record, independent citation reliance, peer trust indicators, and continued U.S.-based research focused on improving neuromodulation evidence and neurological disorder management.